IRIS Institutional Research Information System - OPENBS Open Archive UniBS

ROMANI, Chiara
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 5.060
EU - Europa 2.258
AS - Asia 2.225
SA - Sud America 334
AF - Africa 51
OC - Oceania 9
Continente sconosciuto - Info sul continente non disponibili 3
AN - Antartide 1
Totale 9.941
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.944
SG - Singapore 768
CN - Cina 679
PL - Polonia 617
IT - Italia 443
BR - Brasile 276
DE - Germania 268
UA - Ucraina 250
HK - Hong Kong 234
VN - Vietnam 167
FI - Finlandia 159
GB - Regno Unito 115
FR - Francia 103
TR - Turchia 79
CA - Canada 72
BD - Bangladesh 68
IN - India 65
IE - Irlanda 64
RU - Federazione Russa 61
NL - Olanda 37
ID - Indonesia 33
SE - Svezia 29
AR - Argentina 28
MX - Messico 28
ZA - Sudafrica 24
EE - Estonia 23
IQ - Iraq 23
ES - Italia 19
JP - Giappone 19
AT - Austria 11
CZ - Repubblica Ceca 11
PK - Pakistan 11
BE - Belgio 10
LT - Lituania 9
AU - Australia 8
KG - Kirghizistan 8
EC - Ecuador 7
BG - Bulgaria 6
CO - Colombia 6
KR - Corea 6
NP - Nepal 6
TW - Taiwan 6
AE - Emirati Arabi Uniti 5
CL - Cile 5
LK - Sri Lanka 5
MA - Marocco 5
SA - Arabia Saudita 5
AZ - Azerbaigian 4
EG - Egitto 4
IL - Israele 4
JO - Giordania 4
KZ - Kazakistan 4
MY - Malesia 4
NG - Nigeria 4
NI - Nicaragua 4
PH - Filippine 4
PY - Paraguay 4
UZ - Uzbekistan 4
CR - Costa Rica 3
DZ - Algeria 3
EU - Europa 3
HN - Honduras 3
KE - Kenya 3
PT - Portogallo 3
VE - Venezuela 3
AL - Albania 2
BN - Brunei Darussalam 2
BY - Bielorussia 2
HU - Ungheria 2
LU - Lussemburgo 2
LV - Lettonia 2
OM - Oman 2
PE - Perù 2
RO - Romania 2
SK - Slovacchia (Repubblica Slovacca) 2
TH - Thailandia 2
TN - Tunisia 2
TT - Trinidad e Tobago 2
UY - Uruguay 2
AM - Armenia 1
AQ - Antartide 1
BB - Barbados 1
BH - Bahrain 1
BO - Bolivia 1
BW - Botswana 1
CH - Svizzera 1
CI - Costa d'Avorio 1
DK - Danimarca 1
ET - Etiopia 1
GD - Grenada 1
GR - Grecia 1
IR - Iran 1
JM - Giamaica 1
KH - Cambogia 1
LY - Libia 1
ML - Mali 1
MT - Malta 1
MU - Mauritius 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
Totale 9.939
Salva come PNG Salva come JPEG
Città #
Warsaw 612
Ashburn 518
Fairfield 466
Singapore 454
Woodbridge 328
San Jose 300
Houston 283
Chandler 241
Seattle 219
Hong Kong 213
New York 186
Jacksonville 175
Wilmington 165
Beijing 146
Cambridge 143
The Dalles 142
Ann Arbor 128
Los Angeles 128
Dearborn 106
Helsinki 104
Princeton 101
Brescia 96
Dublin 64
Nanjing 63
Council Bluffs 61
Istanbul 59
Munich 59
Lauterbourg 55
Dallas 53
Milan 51
Shanghai 45
Dong Ket 44
Buffalo 40
Ho Chi Minh City 39
São Paulo 37
Chicago 33
London 33
Des Moines 31
Hanoi 31
San Francisco 30
Moscow 29
Toronto 27
Orem 25
Santa Clara 24
Denver 23
Jakarta 23
Tallinn 23
San Diego 21
Montreal 20
Redondo Beach 20
Shenyang 20
Tianjin 20
Jinan 19
Johannesburg 19
Turku 19
Chennai 18
Nanchang 18
Tokyo 17
Brooklyn 16
Rome 16
Kunming 15
Phoenix 15
Central 14
Changsha 14
Hangzhou 14
Nuremberg 14
Hebei 13
Poplar 13
Guangzhou 12
Jiaxing 12
Stockholm 12
Charlotte 11
Paris 11
Zhengzhou 11
Atlanta 10
Boston 10
Manchester 10
Mexico City 10
Monmouth Junction 10
Kyiv 9
Amsterdam 8
Ankara 8
Belo Horizonte 8
Bishkek 8
Lappeenranta 8
Mumbai 8
Brussels 7
Falkenstein 7
Frankfurt am Main 7
Haiphong 7
Leawood 7
Miami 7
Norwalk 7
Rio de Janeiro 7
Vancouver 7
Verona 7
Baghdad 6
Boardman 6
Curitiba 6
Da Nang 6
Totale 6.881
Salva come PNG Salva come JPEG
Nome #
Identification of stably expressed reference small non-coding RNAs for microRNA quantification in high-grade serous ovarian carcinoma tissues 361
Proc Natl Acad Sci U S A. 2013 Feb 19;110(8):2916-21. doi: 10.1073/pnas.1222577110. Epub 2013 Jan 28. Landscape of somatic single-nucleotide and copy-number mutations in uterine serous carcinoma. Zhao S1, Choi M, Overton JD, Bellone S, Roque DM, Cocco E, Guzzo F, English DP, Varughese J, Gasparrini S, Bortolomai I, Buza N, Hui P, Abu-Khalaf M, Ravaggi A, Bignotti E, Bandiera E, Romani C, Todeschini P, Tassi R, Zanotti L, Carrara L, Pecorelli S, Silasi DA, Ratner E, Azodi M, Schwartz PE, Rutherford TJ, Stiegler AL, Mane S, Boggon TJ, Schlessinger J, Lifton RP, Santin AD 356
Diagnostic and prognostic impact of serum HE4 detection in endometrial carcinoma patients. 331
Claudin3 is localized outside the tight junctions in human carcinomas 293
Evaluation of a novel human IgG1 anti-claudin3 antibody that specifically recognizes its aberrantly localized antigen in ovarian cancer cells and that is suitable for selective drug delivery 286
Cancer antigen 125, human epididymis 4, kallikrein 6, osteopontin and soluble mesothelin-related peptide immunocomplexed with immunoglobulin M in epithelial ovarian cancer diagnosis. 224
Correlation between serological immune response analyzed by a new ELISA for HPV-16/18 E7 oncoprotein and clinical characteristics of cervical cancer patients. 219
Epidermal growth factor receptor detection in serum and saliva as a diagnostic and prognostic tool in oral cancer 213
Class III β-tubulin overexpression in ovarian clear cell and serous carcinoma as a maker for poor overall survival after platinum/taxane chemotherapy and sensitivity to patupilone 210
Differential gene expression profiles between tumor biopsies and short-term primary cultures of ovarian serous carcinomas: identification of novel molecular biomarkers for early diagnosis and therapy. 204
Landscape of somatic single-nucleotide and copy-number mutations in uterine serous carcinoma 203
FOXM1 expression is significantly associated with chemotherapy resistance and adverse prognosis in non-serous epithelial ovarian cancer patients 202
Secretoglobin expression in ovarian carcinoma: lipophilin B gene upregulation as an independent marker of better prognosis. 201
Gene expression profiling to improve prognostic characterization of olfactory neuroblastoma and to define new targetable pathways 193
Trop-2 overexpression as an independent marker for poor overall survival in ovarian carcinoma patients. 188
Identification of optimal reference genes for gene expression normalization in a wide cohort of endometrioid endometrial carcinoma tissues. 186
Trop-2 protein overexpression is an independent marker for predicting disease recurrence in endometrioid endometrial carcinoma 181
Immunotherapy for the prevention of high-risk oral disorders malignant transformation: the IMPEDE trial 178
Mammaglobin B is an independent prognostic marker in epithelial ovarian cancer and its expression is associated with reduced risk of disease recurrence 177
Gene Expression Clustering and Selected Head and Neck Cancer Gene Signatures Highlight Risk Probability Differences in Oral Premalignant Lesions 177
Development and characterization of a human single-chain antibody fragment against claudin-3: a novel therapeutic target in ovarian and uterine carcinomas. 176
Serum human epididymis protein 4 and risk for ovarian malignancy algorithm as new diagnostic and prognostic tools for epithelial ovarian cancer management. 176
MAL gene overexpression as a marker of high-grade serous ovarian carcinoma stem-like cells that predicts chemoresistance and poor prognosis 174
Prognosis and management of recurrent and/or metastatic head and neck adenoid cystic carcinoma 174
Mutational landscape of uterine and ovarian carcinosarcomas implicates histone genes in epithelial-mesenchymal transition 173
Genome-wide study of salivary miRNAs identifies miR-423-5p as promising diagnostic and prognostic biomarker in oral squamous cell carcinoma 169
Trefoil factor 3: a novel serum marker identified by gene expression profiling in highgrade endometrial carcinomas 168
HPV16/18 E7-pulsed dendritic cell vaccination in cervical cancer patients with recurrent disease refractory to standard treatment modalities. 166
Human epididymis protein 4 as a serum marker for diagnosis of endometrial carcinoma and prediction of clinical outcome 153
The HIV-protease inhibitor saquinavir reduces proliferation, invasion and clonogenicity in cervical cancer cell lines 150
Claudin 7 downregulation is predictive of distant metastasis in high-grade serous carcinoma patients 146
Gene expression profiling of olfactory neuroblastoma helps identify prognostic pathways and define potentially therapeutic targets 142
Expression profiles of PRKG1, SDF2L1 and PPP1R12A are predictive and prognostic factors for therapy response and survival in high-grade serous ovarian cancer 141
Polymerase ε (POLE) ultra-mutation in uterine tumors correlates with T lymphocyte infiltration and increased resistance to platinum-based chemotherapy in vitro 140
Low Expression of Claudin-7 as Potential Predictor of Distant Metastases in High-Grade Serous Ovarian Carcinoma Patients 133
Clinical and Histological Prognostic Factors of Recurrence and Malignant Transformation in a Large Series of Oral Potentially Malignant Disorders 131
Prenatal presentation and postnatal evolution of a patient with Jansen metaphyseal dysplasia with a novel missense mutation in PTH1R. 131
The claudin-low subtype of high-grade serous ovarian carcinoma exhibits stem cell features 130
Functional profiles of curatively treated adenoid cystic carcinoma unveil prognostic features and potentially targetable pathways 129
Uso di miRNA come biomarcatori per la diagnosi e prognosi del carcinoma orale a cellule squamose 127
Stability of circulating miRNA in saliva: The influence of sample associated pre-analytical variables 122
Pre-treatment Serum HE4 Level as a Novel Independent Prognostic Biomarker for Uterine Cervical Carcinoma Patients 120
Human kallikrein 5: an interesting novel biomarker in ovarian cancer patients that elicits humoral response. 117
New Challenges in Evaluating Outcomes after Immunotherapy in Recurrent and/or Metastatic Head and Neck Squamous Cell Carcinoma 115
Integrated mutational landscape analysis of uterine leiomyosarcomas 115
OVEREXPRESSION OF EPIDERMAL GROWTH FACTOR TYPE-1 RECEPTOR (EGF-R1) IN CERVICAL CANCER: IMPLICATIONS FOR CETUXIMAB-MEDIATED THERAPY IN RECURRENT/METASTATIC DISEASE. 115
Integrated Biomarker Analysis Reveals L1CAM as a Potential Stratification Marker for No Specific Molecular Profile High-Risk Endometrial Carcinoma 113
FXYD5 (Dysadherin) upregulation predicts shorter survival and reveals platinum resistance in high-grade serous ovarian cancer patients 112
L1CAM expression as a predictor of platinum response in high-risk endometrial carcinoma 109
HE4 and epithelial ovarian cancer : Comparison and clinical evaluation of two immunoassays and a combination algorithm 106
The expression level of VEGFR2 regulates mechanotransduction, tumor growth and metastasis of high grade serous ovarian cancer cells 104
Human papillomavirus type 16 (HPV-16) virus-like particleL1-specific CD8+ cytotoxic T lymphocytes (CTLs) are equally effective as E7-specific CD8+ CTLs in killing autologous HPV-16-positive tumor cells in cervical cancer patients: implications for L1 dendritic cell-based therapeutic vaccines. 102
Trop-2 Overexpression in Poorly Differentiated Endometrial Endometrioid Carcinoma: Implications for Immunotherapy With hRS7, a Humanized Anti-Trop-2 Monoclonal Antibody 97
Mutational landscape of primary, metastatic, and recurrent ovarian cancer reveals c-MYC gains as potential target for BET inhibitors 95
Comprehensive Profiling of Hypoxia-Related miRNAs Identifies miR-23a-3p Overexpression as a Marker of Platinum Resistance and Poor Prognosis in High-Grade Serous Ovarian Cancer 91
Correction for Li et al., Mutational landscape of primary, metastatic, and recurrent ovarian cancer reveals c-MYC gains as potential target for BET inhibitors 87
Whole-exome sequencing of cervical carcinomas identifies activating ERBB2 and PIK3CA mutations as targets for combination therapy 85
The VEGF/VEGFR2 system in ovarian cancer: From functional to pharmacological significance 84
Revisiting the concept of neoadjuvant and induction therapy in head and neck cancer with the advent of immunotherapy 82
Finding the junction between claudins and endometrial carcinoma 81
The prognostic role of salivary miRNAs in oral squamous cell carcinoma: technical challenges and clinical perspectives 74
Identification of optimal reference RNAs to normalize miRNA expression data by qRT-PCR in formalin-fixed, paraffin-embedded lymph node tissue 71
Bacterial cytoplasm as an effective cell compartment for producing functional VHH-based affinity reagents and Camelidae IgG-like recombinant antibodies 70
The interplay of hypoxia, inflammation, and microbiota as indicators of malignant transformation in oral potentially malignant disorders 64
VEGF-D Serum Level as a Potential Predictor of Lymph Node Metastasis and Prognosis in Vulvar Squamous Cell Carcinoma Patients 51
Mammaglobin B (SCGB2A1) is a novel tumor antigen highly differentially expressed in all major histological types of ovarian cancer: implications for ovarian cancer immunotherapy 43
HPV16VLP L1-Specific CD8+ cytotoxic T lymphocytes (CTL) are equally effective as E7-specific CD8+ CTL in killing autologous HPV16 positive tumor cells in cervical cancer patients: implications for L1 dendritic cell-based therapeutic vaccines 41
Aberrant VEGFR2 supports tumor growth by extracellular matrix remodeling 21
Totale 10.099
Salva come PNG Salva come JPEG
Categoria #
all - tutte 44.851
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 44.851
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202172 0 0 0 0 0 0 0 0 0 0 0 72
2021/2022544 64 92 11 3 5 32 48 28 26 97 38 100
2022/2023611 90 38 32 40 60 126 8 66 84 6 35 26
2023/2024775 38 25 78 56 43 189 45 45 124 44 15 73
2024/20251.425 28 41 29 246 112 148 109 51 137 94 265 165
2025/20263.313 310 273 213 472 391 263 562 134 207 285 173 30
Totale 10.099